Conference coverage: 2020 Employers Cancer Care Summit

On March 3, the 2020 Employers Cancer Care Summit featured sessions on cancer-related issues and opportunities tied to benefits plans and the workplace.

Many perspectives required when covering cancer drugs on benefits plans
While treatment options for cancer are more than they used to be, many still aren’t covered under the public health-care system, according to Tim Clarke, president of TC Health Consulting Inc. Read more.

Immunotherapy innovations beneficial in kidney cancer treatment
While kidney cancer is uncommon in patients younger than age 45, there’s an increasing incidence in diagnosis in young people because of the advent of imaging technology, according to Dr. Nazanin Fallah-Rad, medical oncologist at Princess Margaret Cancer Centre and Mount Sinai Hospital. Read more.

Flexible return-to-work policies crucial for cancer survivors
By the year 2031, 2.2 million Canadians will be living with cancer, with 40 per cent between the ages of 20 and 65 — the typical working years, according to Maureen Parkinson, provincial rehabilitation counsellor at B.C. Cancer Agency and co-director of Cancer and Work. Read more.

Fidelity Canada touts preventative, life-sustaining benefits plans
When it comes to benefits plan management, each case is individual, said Diana Godfrey, senior vice-president of human resources and corporate at Fidelity Canada. Read more.

Ignoring psychosocial oncology can be costly for organizations
When a person experiences a cancer diagnosis and undergoes treatment, it can be one of the most distressing experiences they can go through, so it’s important for employers to understand psychosocial oncology. Read more.